2

SilcsBio, LLC Announces Release of CGenFF 2.1.0

SilcsBio, LLC Announces Release of CGenFF 2.1.0March 4, 2017Baltimore, MD, 4 March 2017 In ongoing efforts to improve the coverage of the CGenFF program, version 2.1.0 of the CGenFF program extends support to the S-P bond found in the GTP-gamma like molecules. Bonded parameters and charge-distribution along...

SilcsBio, LLC Announces Release of CGenFF 2.0.0

SilcsBio, LLC Announces Release of CGenFF 2.0.0December 27, 2016Baltimore, MD, 15 November 2016 Version 2.0.0 is the second release of CGenFF program, extending support to a larger variety of drug-like molecules to be used routinely in Computer-Aided Drug Design projects. Specifically, it improves treatment of...

SilcsBio, LLC Receives Phase II NIH SBIR Funding

SilcsBio, LLC Receives Phase II NIH SBIR FundingJuly 8, 2016  FOR IMMEDIATE RELEASE: July 7, 2016 Ken Malone SilcsBio, LLC 410.929.2305 Ken.Malone@silcsbio.com   SilcsBio, LLC Receives Phase II NIH SBIR Funding   Baltimore, Maryland: SilcsBio, LLC announced today a $1.3 million funding award from the...